It makes complete sense. If the convalescent plasma provides antibodies to fight the virus, there is no reason why it couldn't be injected to allow a person to trigger it's own growth of antibodies.
By Emily Baumgaertener
A man receives a shot in a clinical trial of a potential vaccine for COVID-19.
It might be the next best thing to a coronavirus vaccine. (click here)
Scientists have devised a way to use the antibody-rich blood plasma of COVID-19 survivors for an upper-arm injection that they say could inoculate people against the virus for months.
Using technology that’s been proven effective in preventing other diseases such as hepatitis A, the injections would be administered to high-risk healthcare workers, nursing home patients, or even at public drive-through sites — potentially protecting millions of lives, the doctors and other experts say.
The two scientists who spearheaded the proposal — an 83-year-old shingles researcher and his counterpart, an HIV gene therapy expert — have garnered widespread support from leading blood and immunology specialists, including those at the center of the nation’s COVID-19 plasma research.
But the idea exists only on paper. Federal officials have twice rejected requests to discuss the proposal, and pharmaceutical companies — even acknowledging the likely efficacy of the plan — have declined to design or manufacture the shots, according to a Times investigation. The lack of interest in launching development of immunity shots comes amid heightened scrutiny of the federal government’s sluggish pandemic response....
There is plenty of money for this in the pipeline. Why isn't it being pursued for manufacturing and distributing?
The only concern appears to be the injection could spawn the virus, but, convalescent plasma doesn't contain the virus, just the antibodies to fight the virus.
